| For: | Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007; 13(47): 6419-6424 [PMID: 18081233 DOI: 10.3748/wjg.v13.i47.6419] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i47/6419.htm |
| Number | Citing Articles |
| 1 |
Neeraj Bhala, Jacob George. The Burden of Non-alcoholic Fatty Liver Disease (NAFLD) in the Asia Pacific Region. Current Hepatology Reports 2015; 14(2) doi: 10.1007/s11901-015-0264-8
|
| 2 |
L.M. Sarmiento Méndez, A. Roca-Cusachs Coll, J.A. Arroyo Díaz, M.T. Benet Gustà, M.J. Solé Villa, M. Franco Peral. Comparación de las definiciones de síndrome metabólico según ATP III e IDF. Revista Clínica Española 2008; 208(7) doi: 10.1157/13124312
|
| 3 |
Chanbin Lee, Jieun Kim, Jinsol Han, Dayoung Oh, Minju Kim, Hayeong Jeong, Tae-Jin Kim, Sang-Woo Kim, Jeong Nam Kim, Young-Su Seo, Ayako Suzuki, Jae Ho Kim, Youngmi Jung. Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-28138-6
|
| 4 |
Ke Pu, Yuping Wang, Suyang Bai, Hui Wei, Yongning Zhou, Jiangao Fan, Liang Qiao. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0961-9
|
| 5 |
Liu Han, Shifeng Fu, Jianglei Li, Deliang Liu, Yuyong Tan. Association between grip strength and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.988566
|
| 6 |
Nan Zhu, Yongfeng Song, Chen Zhang, Kai Wang, Junming Han. Association between the peripheral neutrophil-to-lymphocyte ratio and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1294425
|
| 7 |
Jinmei Yao, Ying Zhao, Juanwen Zhang, Yani Hong, Huanle Lu, Jianping Wu. Serum amylase levels are decreased in Chinese non-alcoholic fatty liver disease patients. Lipids in Health and Disease 2014; 13(1) doi: 10.1186/1476-511X-13-185
|
| 8 |
Johanna K DiStefano. NAFLD and NASH in Postmenopausal Women: Implications for Diagnosis and Treatment. Endocrinology 2020; 161(10) doi: 10.1210/endocr/bqaa134
|
| 9 |
M. Lemoine, L. Serfaty. Foie métabolique. EMC - Hépatologie 2011; 26(4) doi: 10.1016/S1155-1976(11)54601-7
|
| 10 |
Qian Zhang, Carlos K H Wong, Kenny Kung, Joseph C Y Chan, Barre T W Sy, Marcus Lam, Xiang Gui Xu, Meng Feng Yang, Yang Yu, Xiu Ping Lin, Cindy L K Lam. Development and validation study of a non-alcoholic fatty liver disease risk scoring model among adults in China. Family Practice 2017; 34(6) doi: 10.1093/fampra/cmx049
|
| 11 |
Edith M. Koehler, Jeoffrey N.L. Schouten, Bettina E. Hansen, Frank J.A. van Rooij, Albert Hofman, Bruno H. Stricker, Harry L.A. Janssen. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: Results from the Rotterdam study. Journal of Hepatology 2012; 57(6) doi: 10.1016/j.jhep.2012.07.028
|
| 12 |
I. A. Bulatova, T. P. Shevlyukova. Features of the course of non-alcoholic fatty liver disease in women at different age periods: literature review. Meditsinskiy sovet = Medical Council 2024; (8) doi: 10.21518/ms2024-112
|
| 13 |
John J. Loy, Heekoung A. Youn, Bradley Schwack, Marina Kurian, Christine Ren Fielding, George A. Fielding. Improvement in nonalcoholic fatty liver disease and metabolic syndrome in adolescents undergoing bariatric surgery. Surgery for Obesity and Related Diseases 2015; 11(2) doi: 10.1016/j.soard.2014.11.010
|
| 14 |
Pawan Ghanghoriya, Shipra Mandraha, Chandan Kumar Mishra. Prevalence of non-alcoholic fatty liver disease and its correlation with anthropometric measures and laboratory parameters in overweight and obese children and adolescents. Indian Journal of Child Health 2018; 5(5) doi: 10.32677/IJCH.2018.v05.i05.011
|
| 15 |
Florian Koutny, Elmar Aigner, Christian Datz, Sophie Gensluckner, Andreas Maieron, Andrea Mega, Bernhard Iglseder, Patrick Langthaler, Vanessa Frey, Bernhard Paulweber, Eugen Trinka, Bernhard Wernly. Relationships between education and non-alcoholic fatty liver disease. European Journal of Internal Medicine 2023; 118 doi: 10.1016/j.ejim.2023.07.039
|
| 16 |
Khean-Lee Goh. Emerging Gastrointestinal and Liver Diseases in Asia Pacific: Implications to Health Care in the Region (World Gastroenterology Organization: Asian Pacific Association of Gastroenterology Distinguished Global Lecture 2015). Journal of Clinical Gastroenterology 2017; 51(6) doi: 10.1097/MCG.0000000000000847
|
| 17 |
Zhe Shen, Youming Li, Chaohui Yu, Yi Shen, Lei Xu, Chengfu Xu, Genyun Xu. A cohort study of the effect of alcohol consumption and obesity on serum liver enzyme levels. European Journal of Gastroenterology & Hepatology 2010; 22(7) doi: 10.1097/MEG.0b013e3283328b86
|
| 18 |
Miguel Malespin, Brett Sleesman, Alan Lau, Shirley S. Wong, Scott J. Cotler. Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese American Children. Journal of Clinical Gastroenterology 2015; 49(4) doi: 10.1097/MCG.0000000000000121
|
| 19 |
Liyun Yuan, Ani Kardashian, Monika Sarkar. NAFLD in Women: Unique Pathways, Biomarkers, and Therapeutic Opportunities. Current Hepatology Reports 2019; 18(4) doi: 10.1007/s11901-019-00495-9
|
| 20 |
Amedeo Lonardo, Ayako Suzuki. Sexual Dimorphism of NAFLD in Adults. Focus on Clinical Aspects and Implications for Practice and Translational Research. Journal of Clinical Medicine 2020; 9(5) doi: 10.3390/jcm9051278
|
| 21 |
Sumio Watanabe, Nobuyuki Enomoto, Kazuhiko Koike, Namiki Izumi, Hajime Takikawa, Etsuko Hashimoto, Fuminori Moriyasu, Hiromitsu Kumada, Michio Imawari. Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real‐life setting in Japan. Hepatology Research 2010; 40(2) doi: 10.1111/j.1872-034X.2009.00567.x
|
| 22 |
Michael H. Le, Yee Hui Yeo, Xiaohe Li, Jie Li, Biyao Zou, Yuankai Wu, Qing Ye, Daniel Q. Huang, Changqing Zhao, Jie Zhang, Chenxi Liu, Na Chang, Feng Xing, Shiping Yan, Zi Hui Wan, Natasha Sook Yee Tang, Maeda Mayumi, Xinting Liu, Chuanli Liu, Fajuan Rui, Hongli Yang, Yao Yang, Ruichun Jin, Richard H.X. Le, Yayun Xu, David M. Le, Scott Barnett, Christopher Donald Stave, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen. 2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2022; 20(12) doi: 10.1016/j.cgh.2021.12.002
|
| 23 |
S. J. Cotler, M. K. Dhamija, B. J. Luc, F. Siqueira, A. H. Bartram, T. J. Layden, S. S. Wong. The prevalence and clinical correlates of elevated ALT levels in an urban Chinatown community. Journal of Viral Hepatitis 2010; 17(2) doi: 10.1111/j.1365-2893.2009.01162.x
|
| 24 |
Jin-Zhou Zhu, Yi-Ning Dai, Yu-Ming Wang, Qin-Yi Zhou, Chao-Hui Yu, You-Ming Li. Prevalence of Nonalcoholic Fatty Liver Disease and Economy. Digestive Diseases and Sciences 2015; 60(11) doi: 10.1007/s10620-015-3728-3
|
| 25 |
Jin-Zhou Zhu, Qin-Yi Zhou, Yu-Ming Wang, Yi-Ning Dai, Jiang Zhu, Chao-Hui Yu, You-Ming Li. Prevalence of fatty liver disease and the economy in China: A systematic review. World Journal of Gastroenterology 2015; 21(18): 5695-5706 doi: 10.3748/wjg.v21.i18.5695
|
| 26 |
Lei Li, Sheng-he Li, Jin-peng Jiang, Chang Liu, Li-li Ji. Investigating pharmacological mechanisms of andrographolide on non-alcoholic steatohepatitis (NASH): A bioinformatics approach of network pharmacology. Chinese Herbal Medicines 2021; 13(3) doi: 10.1016/j.chmed.2021.05.001
|
| 27 |
Yu‐Qiang Nie, Jie Cao, Yong‐Jian Zhou, Xia Liang, Yan‐Lei Du, Yu‐Jui Yvonne Wan, Yu‐Yuan Li. The Effect of miRNA‐122 in Regulating Fat Deposition in a Cell Line Model. Journal of Cellular Biochemistry 2014; 115(5) doi: 10.1002/jcb.24725
|
| 28 |
Zhen Cheng, Chunyu Hu, Yalan Zhang, Jie Zhou, Jiayang Shi, Li Sun, Zongtao Chen. The Different Predictive Effects of Multiple Body Fat Indexes on Metabolic Dysfunction-Associated Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 2024; doi: 10.2147/DMSO.S469859
|
| 29 |
James E. Everhart, Kiran M. Bambha. Fatty Liver: Think Globally. Hepatology 2010; 51(5) doi: 10.1002/hep.23659
|
| 30 |
Stefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, Alessandra Marrazzo, Dante Romagnoli, Amedeo Lonardo. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk. Advances in Therapy 2017; 34(6) doi: 10.1007/s12325-017-0556-1
|
| 31 |
Atoosa Adibi, Shahab Maleki, Peyman Adibi, Reza Etminani, Silva Hovsepian. Prevalence of Nonalcoholic Fatty Liver Disease and its Related Metabolic Risk Factors in Isfahan, Iran. Advanced Biomedical Research 2017; 6(1) doi: 10.4103/2277-9175.204590
|
| 32 |
Yinxia Su, Zhenhui Liu, Lei Yang, Yuanyuan Li, Sheng Jiang, Hua Yao, Guoli Du. PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China. Clinics and Research in Hepatology and Gastroenterology 2020; 44(6) doi: 10.1016/j.clinre.2020.02.005
|
| 33 |
Shiva Kargar, Hossein Ansari. Prevalence of dyslipidemias in the Middle East region: A systematic review & meta-analysis study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2023; 17(11) doi: 10.1016/j.dsx.2023.102870
|
| 34 |
Jun Luo, Li Xu, Jiang Li, Shuiping Zhao. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. European Journal of Gastroenterology & Hepatology 2015; 27(3) doi: 10.1097/MEG.0000000000000254
|
| 35 |
Gang Chen, Ling Chen, Baoying Huang, Changsheng Qiu, Jieli Lu, Yufang Bi, Guang Ning, Jixing Liang, Junping Wen. Is Alanine Aminotransferase Associated with Osteopenia in Middle-Aged and Elderly Chinese?. Endocrine Practice 2014; 20(8) doi: 10.4158/EP13166.OR
|
| 36 |
A. Asgari-Kafrani, M. Fazilati, H. Nazem. Hepatoprotective and antioxidant activity of aerial parts of Moringa oleifera in prevention of non-alcoholic fatty liver disease in Wistar rats. South African Journal of Botany 2020; 129 doi: 10.1016/j.sajb.2019.01.014
|
| 37 |
Zongzhe Tang, Yajie Ding, Wei Zhang, Ru Zhang, Liuxin Zhang, Minxian Wang, Min Wang, Yue Chen, Jie Wang. Epidemiological characteristics of alcohol-related liver disease in China: a systematic review and meta-analysis. BMC Public Health 2023; 23(1) doi: 10.1186/s12889-023-15645-4
|
| 38 |
Ying-Chin Lin, Shou-Chu Chou, Pai-Tsang Huang, Hung-Yi Chiou. Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan. Annals of Hepatology 2011; 10(2) doi: 10.1016/S1665-2681(19)31560-1
|
| 39 |
Elena Succurro, Maria Adelaide Marini, Teresa Vanessa Fiorentino, Maria Perticone, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti. Sex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes. Diabetes Research and Clinical Practice 2022; 190 doi: 10.1016/j.diabres.2022.110027
|
| 40 |
Xiaohua Yan, Liyun Xu, Jianni Qi, Xiaohong Liang, Chunhong Ma, Chun Guo, Lining Zhang, Wensheng Sun, Jiyun Zhang, Xiaoyi Wei, Lifen Gao. sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics 2009; 61(8) doi: 10.1007/s00251-009-0389-4
|
| 41 |
Peiyi Liu, Yuhan Tang, Xiaoping Guo, Xinhong Zhu, Meian He, Jing Yuan, Youjie Wang, Sheng Wei, Weihong Chen, Xiaomin Zhang, Xiaoping Miao, Ping Yao. Bidirectional association between nonalcoholic fatty liver disease and hypertension from the Dongfeng-Tongji cohort study. Journal of the American Society of Hypertension 2018; 12(9) doi: 10.1016/j.jash.2018.06.013
|
| 42 |
Hejun Li, Ying Zhang, Hengcong Luo, Rong Lin. The lipid accumulation product is a powerful tool to diagnose metabolic dysfunction-associated fatty liver disease in the United States adults. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.977625
|
| 43 |
Da Gan, Lu Wang, Menghan Jia, Yuan Ru, Yiyun Ma, Weifang Zheng, Xueyin Zhao, Fei Yang, Tianru Wang, Yun Mu, Shankuan Zhu. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clinical Nutrition 2020; 39(4) doi: 10.1016/j.clnu.2019.04.023
|
| 44 |
Carl Kay, Kendra Stilwell, James Aden, Amilcar Morales‐Cardona. Surgical menopause may not increase the risk of non‐alcoholic fatty liver disease. GastroHep 2020; 2(5) doi: 10.1002/ygh2.422
|
| 45 |
Yajie Zhang, Dajiang Lu, Renwei Wang, Weijie Fu, Shengnian Zhang. Relationship between Muscle Mass/Strength and Hepatic Fat Content in Post-Menopausal Women. Medicina 2019; 55(10) doi: 10.3390/medicina55100629
|
| 46 |
Catherine Behzad, Zainab Shateri, Nima Motamed, Mansooreh Maadi, Hossein Ajdarkosh, Elham Sobhrakhshankhah, Farhad Zamani, Azam Doustmohammadian, Mehran Nouri. Association of cardiometabolic index with non-alcoholic fatty liver disease among Iranian adults of the amol cohort study. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04271-6
|
| 47 |
Keping Peng, Zengnan Mo, Guixiang Tian. Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males. The American Journal of the Medical Sciences 2017; 353(3) doi: 10.1016/j.amjms.2017.01.002
|
| 48 |
Xu‐hong Hou, Yun‐xia Zhu, Hui‐juan Lu, Hui‐fen Chen, Qiang Li, Shan Jiang, Kun‐san Xiang, Wei‐ping Jia. Non‐alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. Journal of Gastroenterology and Hepatology 2011; 26(4) doi: 10.1111/j.1440-1746.2010.06509.x
|
| 49 |
Shaman Rajindrajith, Arunasalam Pathmeswaran, Chamilka Jayasinghe, Dulani Kottahachchi, Anuradhani Kasturiratne, Shamila T. de Silva, Madunil A. Niriella, Anuradha S. Dassanayake, Arjuna P. de Silva, H. Janaka de Silva. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community. BMC Gastroenterology 2017; 17(1) doi: 10.1186/s12876-017-0677-7
|
| 50 |
Bo Yang Su, Song Wang, Tie Jun Liu, Yan Leng, Zhi Yuan Liu, Lu Liu, Zhuang Xiong. Association between weekend warriors and MASLD—a cross-sectional study of the NHANES database 2017–2020. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1531437
|
| 51 |
Yong‐Jian Zhou, Yu‐Yuan Li, Yu‐Qiang Nie, Hui Yang, Qi Zhan, Jian Huang, Sheng‐Li Shi, Xiao‐Bo Lai, Hong‐Li Huang. Influence of polygenetic polymorphisms on the susceptibility to non‐alcoholic fatty liver disease of Chinese people. Journal of Gastroenterology and Hepatology 2010; 25(4) doi: 10.1111/j.1440-1746.2009.06144.x
|
| 52 |
G. Vernon, A. Baranova, Z. M. Younossi. Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults. Alimentary Pharmacology & Therapeutics 2011; 34(3) doi: 10.1111/j.1365-2036.2011.04724.x
|
| 53 |
Guruprasad P. Aithal, Kshaunish Das, Abhijit Chowdhury. GI Epidemiology. 2014; doi: 10.1002/9781118727072.ch32
|
| 54 |
Yingzi Ming, Quan Zhuang, Baoren Tu, Gangcheng Kong, Hao Li, Ying Niu, Bo Peng, Junhui Li, Meng Yu, Min Yang. Surgical Challenges in the Management of Liver Disease. 2019; doi: 10.5772/intechopen.81230
|
| 55 |
Mamun Al Mahtab, Jhumur Ghosh, Shobna Bhatia, Aabha Nagral, Manisha Bangar, Sherna Menezes, Nazish Butt, Jayani Harshika Manchanayake, Shivaram Prasad Singh. Gender Differences in Nonalcoholic Fatty Liver Disease. Euroasian Journal of Hepato-Gastroenterology 2022; 12(S1) doi: 10.5005/jp-journals-10018-1370
|
| 56 |
Miriam B. Vos, Craig J. McClain. Nutrition and nonalcoholic fatty liver disease in children. Current Diabetes Reports 2008; 8(5) doi: 10.1007/s11892-008-0069-z
|
| 57 |
Weihao Wang, Yanhua Ma, Zihao Chen, Jingtao Qiao, Pei Xiao, Ran Wei, Xun Jiang, Danni Gao, Jian Shao, Jun Yu, Kaixin Zhou, Ying Li, Ying Pan, Qi Pan, Tong Jia, Lixin Guo. Data-driven subgroups for 3-year risk stratification of incident diabetes and complications in diabetes-free Chinese adults. Chinese Medical Journal 2026; 139(9) doi: 10.1097/CM9.0000000000003953
|
| 58 |
Corinna Koebnick, Darios Getahun, Kristi Reynolds, Karen J Coleman, Amy H Porter, Jean M Lawrence, Mark Punyanitya, Virginia P Quinn, Steven J Jacobsen. Trends in Nonalcoholic Fatty Liver Disease–related Hospitalizations in US Children, Adolescents, and Young Adults. Journal of Pediatric Gastroenterology and Nutrition 2009; 48(5) doi: 10.1097/MPG.0b013e318192d224
|
| 59 |
Zobair Younossi, Quentin M. Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2018; 15(1) doi: 10.1038/nrgastro.2017.109
|
| 60 |
Mohamed El-Kassas, Joaquín Cabezas, Paula Iruzubieta Coz, Ming-Hua Zheng, Juan Pablo Arab, Abeer Awad. Nonalcoholic Fatty Liver Disease: Current Global Burden. Seminars in Liver Disease 2022; 42(03) doi: 10.1055/a-1862-9088
|
| 61 |
Yu Yuan Li, Dan Tang, Yan Lei Du, Chuang Yu Cao, Yu Qiang Nie, Jie Cao, Yong Jian Zhou. Fatty liver mediated by peroxisome proliferator‐activated receptor‐α DNA methylation can be reversed by a methylation inhibitor and curcumin. Journal of Digestive Diseases 2018; 19(7) doi: 10.1111/1751-2980.12610
|
| 62 |
Ching-Sheng Hsu, Jia-Horng Kao. An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia. Expert Review of Gastroenterology & Hepatology 2017; 11(8) doi: 10.1080/17474124.2017.1342535
|
| 63 |
Jianping Yang, Qinzhi Wei, Xiaochun Peng, Xiaowu Peng, Jianhui Yuan, Dalin Hu. Relationship between Methyl Tertiary Butyl Ether Exposure and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Petrol Station Attendants in Southern China. International Journal of Environmental Research and Public Health 2016; 13(10) doi: 10.3390/ijerph13100946
|
| 64 |
YI WANG, YU YUAN LI, YU QIANG NIE, YONG JIAN ZHOU, CHUANG YU CAO, LIN XU. Association between metabolic syndrome and the development of non-alcoholic fatty liver disease. Experimental and Therapeutic Medicine 2013; 6(1) doi: 10.3892/etm.2013.1090
|
| 65 |
Yen-Han Lee, Yen-Chang Chang, Ching-Ti Liu, Mack Shelley. Correlates of alcohol consumption and alcohol dependence among older adults in contemporary China: Results from the Chinese Longitudinal Healthy Longevity Survey. Journal of Ethnicity in Substance Abuse 2020; 19(1) doi: 10.1080/15332640.2018.1456388
|
| 66 |
Huapeng Lin, Xinrong Zhang, Guanlin Li, Grace Lai-Hung Wong, Vincent Wai-Sun Wong. Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2021.00201
|
| 67 |
Jian-Gao Fan, Geoffrey C. Farrell. Epidemiology of non-alcoholic fatty liver disease in China. Journal of Hepatology 2009; 50(1) doi: 10.1016/j.jhep.2008.10.010
|
| 68 |
Tao-Hsin Tung, Tsung-Hung Chang, Wei-Hsiu Chiu, Tzu-Han Lin, Hui-Chuan Shih, Ming-Huei Chang, Jorn-Hon Liu. Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital. BMC Research Notes 2011; 4(1) doi: 10.1186/1756-0500-4-315
|
| 69 |
Jia Xiao, Jiteng Wang, Feiyue Xing, Tao Han, Rui Jiao, Emily C. Liong, Man-Lung Fung, Kwok-Fai So, George L. Tipoe, Anna Alisi. Zeaxanthin Dipalmitate Therapeutically Improves Hepatic Functions in an Alcoholic Fatty Liver Disease Model through Modulating MAPK Pathway. PLoS ONE 2014; 9(4) doi: 10.1371/journal.pone.0095214
|
| 70 |
Amedeo Lonardo, Stefano Bellentani, Curtis K. Argo, Stefano Ballestri, Christopher D. Byrne, Stephen H. Caldwell, Helena Cortez-Pinto, Antonio Grieco, Mariana V. Machado, Luca Miele, Giovanni Targher. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease 2015; 47(12) doi: 10.1016/j.dld.2015.08.004
|
| 71 |
Anita Goyal, Hobinder Arora, Sumit Arora. Prevalence of fatty liver in metabolic syndrome. Journal of Family Medicine and Primary Care 2020; 9(7) doi: 10.4103/jfmpc.jfmpc_1108_19
|
| 72 |
Rui Fan, Jufang Wang, Jinman Du. Association between body mass index and fatty liver risk: A dose-response analysis. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-33419-6
|
| 73 |
Bingqian Wang, Wenna Li, Hezhi Fang, Huaibin Zhou. Hepatitis B virus infection is not associated with fatty liver disease: Evidence from a cohort study and functional analysis. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9619
|
| 74 |
Leroy L. Cooper, Brenton R. Prescott, Vanessa Xanthakis, Emelia J. Benjamin, Ramachandran S. Vasan, Naomi M. Hamburg, Michelle T. Long, Gary F. Mitchell. Association of Aortic Stiffness and Pressure Pulsatility With Noninvasive Estimates of Hepatic Steatosis and Fibrosis: The Framingham Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology 2024; 44(7) doi: 10.1161/ATVBAHA.123.320553
|
| 75 |
Ching-Sheng Hsu, Jia-Horng Kao. Management of non-alcoholic fatty liver disease in patients with sarcopenia. Expert Opinion on Pharmacotherapy 2022; 23(2) doi: 10.1080/14656566.2021.1978978
|
| 76 |
You Ming Li, Jian Gao Fan. Guidelines of prevention and treatment for alcoholic liver disease (2018, China). Journal of Digestive Diseases 2019; 20(4) doi: 10.1111/1751-2980.12687
|
| 77 |
M. Shadab Siddiqui, Arun J. Sanyal. Yamada' s Textbook of Gastroenterology. 2015; doi: 10.1002/9781118512074.ch104
|
| 78 |
Chun-Yan Song, Jian Shi, Xin Zeng, Yi Zhang, Wei-Fen Xie, Yue-Xiang Chen. Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway. Toxicology in Vitro 2013; 27(3) doi: 10.1016/j.tiv.2013.01.020
|
| 79 |
Feng-Shang Zhu, Su Liu, Xi-Mei Chen, Zhi-Gang Huang, Dong-Wei Zhang. Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia. World Journal of Gastroenterology 2008; 14(41): 6395-6400 doi: 10.3748/wjg.14.6395
|
| 80 |
Brian Lam, Kyle Kurzke, Zobair Younossi. The Clinical and Economic Burden of Nonalcoholic Steatohepatitis. Current Hepatology Reports 2018; 17(4) doi: 10.1007/s11901-018-0423-9
|
| 81 |
Chun‐Jen Liu. Prevalence and risk factors for non‐alcoholic fatty liver disease in Asian people who are not obese. Journal of Gastroenterology and Hepatology 2012; 27(10) doi: 10.1111/j.1440-1746.2012.07222.x
|
| 82 |
Xia Li, HuiRong Shi, Zhuo Wang, Lei Chang, MingHui Zhang, XiaoFang Dong. Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease. Journal of Hypertension 2017; 35(6) doi: 10.1097/HJH.0000000000001285
|
| 83 |
Hirokazu Takahashi, Masafumi Ono, Hideyuki Hyogo, Chika Tsuji, Yoichiro Kitajima, Naofumi Ono, Takahisa Eguchi, Kazuma Fujimoto, Kazuaki Chayama, Toshiji Saibara, Keizo Anzai, Yuichiro Eguchi. Biphasic effect of alcohol intake on the development of fatty liver disease. Journal of Gastroenterology 2015; 50(11) doi: 10.1007/s00535-015-1058-z
|
| 84 |
Masahiro Sogabe, Toshiya Okahisa, Tatsuya Taniguchi, Tetsu Tomonari, Takahiro Tanaka, Hironori Tanaka, Masahiko Nakasono, Tetsuji Takayama. Light alcohol consumption plays a protective role against non‐alcoholic fatty liver disease in Japanese men with metabolic syndrome. Liver International 2015; 35(6) doi: 10.1111/liv.12754
|
| 85 |
Miriam B. Vos, Craig J. McClain. Nutrition and nonalcoholic fatty liver disease in children. Current Gastroenterology Reports 2008; 10(3) doi: 10.1007/s11894-008-0061-4
|
| 86 |
Emmi Suomela, Mervi Oikonen, Johanna Virtanen, Riitta Parkkola, Eero Jokinen, Tomi Laitinen, Nina Hutri-Kähönen, Mika Kähönen, Terho Lehtimäki, Leena Taittonen, Päivi Tossavainen, Antti Jula, Britt-Marie Loo, Vera Mikkilä, Zobair Younossi, Jorma S. A. Viikari, Markus Juonala, Olli T. Raitakari. Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study. Annals of Medicine 2015; 47(1) doi: 10.3109/07853890.2014.966752
|
| 87 |
Yu Zhang, Liangui Wei, Chunyan Chang, Fangfang Duan, Min Quan, Song Yang. Sarcopenia defined with L3-SMI is an independent predictor of survival in male patients with ARLD in mainland China. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1238433
|
| 88 |
Shu-Fang Xia, Yu-Yu Qiu, Li-Mei Chen, Yu-Yu Jiang, Wei Huang, Zhen-Xing Xie, Xue Tang, Jin Sun. Myricetin alleviated hepatic steatosis by acting on microRNA-146b/thyroid hormone receptor b pathway in high-fat diet fed C57BL/6J mice. Food & Function 2019; 10(3) doi: 10.1039/C8FO01452C
|
| 89 |
H. Castel, P. Mathurin. Stéatohépatite non alcoolique. EMC - Endocrinologie - Nutrition 2011; 22(3) doi: 10.1016/S1155-1941(11)50624-9
|
| 90 |
P. Briseño-Bass, R. Chávez-Pérez, M. López-Zendejas. Prevalencia y relación de esteatosis hepática con perfil lipídico y hepático en pacientes de chequeo médico. Revista de Gastroenterología de México 2019; 84(3) doi: 10.1016/j.rgmx.2018.05.007
|
| 91 |
Alamin Musa, Ibrahim Hadadi, Omer Loaz, Samih Kajoak, Hamid Osman, Saud Aljehani, Mohammed Alwagdani, Mshari Aloufi, Abdulaziz Alnemari, Nasser Althagafi, Ahmad Alotaibi, Mohammed Musleh Alghoraibi, Bushra Abdel Malik, Awadia Gareeballah, Sultan Fahad Alhujaili, Hajir Wahbi, Mayeen Uddin Khandaker. Triple-phase CT evaluation of hepatic lesions in the Saudi population: Assessing diagnostic accuracy. Journal of Radiation Research and Applied Sciences 2025; 18(1) doi: 10.1016/j.jrras.2024.101251
|
| 92 |
ANKITA CHATTERJEE, ANALABHA BASU, ABHIJIT CHOWDHURY, KAUSIK DAS, NEETA SARKAR-ROY, PARTHA P. MAJUMDER, PRIYADARSHI BASU. Comparative analyses of genetic risk prediction methods reveal extreme diversity of genetic predisposition to nonalcoholic fatty liver disease (NAFLD) among ethnic populations of India. Journal of Genetics 2015; 94(1) doi: 10.1007/s12041-015-0494-0
|
| 93 |
Fariborz Mansour-Ghanaei, Farahnaz Joukar, Sahar Najafi Mobaraki, Sara Mavaddati, Soheil Hassanipour, Masood Sepehrimanesh. Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(2) doi: 10.1016/j.dsx.2019.03.009
|
| 94 |
Ghodsiyeh Azarkar, Tayebeh Zeinali, Gholamreza Sharifzadeh, Farshid Abedi, Morteza Hajihosseini, Masood Ziaee. Prevalence of Non-Alcoholic Fatty Liver and its Related Factors in Birjand, During Year 2015. Modern Care Journal 2016; 13(4) doi: 10.5812/modernc.58829
|
| 95 |
Yong Jian ZHOU, Yu Yuan LI, Yu Qiang NIE, Chun Ming HUANG, Chuang Yu CAO. Retracted: Natural course of nonalcoholic fatty liver disease in southern China: A prospective cohort study. Journal of Digestive Diseases 2012; 13(3) doi: 10.1111/j.1751-2980.2011.00571.x
|
| 96 |
Seungho Ryu, Byung-Seong Suh, Yoosoo Chang, Min-Jung Kwon, Kyung Eun Yun, Hyun-Suk Jung, Chan-Won Kim, Bo-Kyoung Kim, Yoo Jin Kim, Yuni Choi, Jiin Ahn, Yong Kyun Cho, Kye-Hyun Kim, Younjhin Ahn, Hyun-Young Park, Eun Chul Chung, Hocheol Shin, Juhee Cho. Menopausal stages and non-alcoholic fatty liver disease in middle-aged women. European Journal of Obstetrics & Gynecology and Reproductive Biology 2015; 190 doi: 10.1016/j.ejogrb.2015.04.017
|
| 97 |
Kanica Kaushal, Smriti Singh, Ankita Anand, Gayatri Ramakrishna, Pratibha Kale, Rishabh Sharma, B.B. Rewari, Shiv K. Sarin. Sex Differences in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Epidemiology, Pathophysiology, and Clinical Implications. Journal of Clinical and Experimental Hepatology 2026; 16(4) doi: 10.1016/j.jceh.2026.103533
|
| 98 |
Masahiro Sogabe, Toshiya Okahisa, Tadahiko Nakagawa, Hiroshi Fukuno, Masahiko Nakasono, Tetsu Tomonari, Takahiro Tanaka, Hironori Tanaka, Tatsuya Taniguchi, Naoki Muguruma, Tetsuji Takayama. Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0431-6
|
| 99 |
Qing Pang, Jing-Yao Zhang, Si-Dong Song, Kai Qu, Xin-Sen Xu, Su-Shun Liu, Chang Liu. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World Journal of Gastroenterology 2015; 21(5): 1650-1662 doi: 10.3748/wjg.v21.i5.1650
|
| 100 |
Sachin Amonker, Aryo Houshmand, Alexander Hinkson, Ian Rowe, Richard Parker. Prevalence of alcohol-associated liver disease: a systematic review and meta-analysis. Hepatology Communications 2023; 7(5) doi: 10.1097/HC9.0000000000000133
|
| 101 |
Katharina Lau, Roberto Lorbeer, Robin Haring, Carsten O Schmidt, Henri Wallaschofski, Matthias Nauck, Ulrich John, Sebastian E Baumeister, Henry Völzke. The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study. Journal of Hypertension 2010; 28(9) doi: 10.1097/HJH.0b013e32833c211b
|
| 102 |
Sobhan Karbas Foroushan, Sina Shokri-Naei, Amirhossein Malaekeh-Nikouei, Mohammad Reza Fadaei, Vafa Baradaran Rahimi, Vahid Reza Askari. Antidotal properties of zeaxanthin as a functional food and one of the most common carotenoids in nature: A review. Journal of Functional Foods 2024; 121 doi: 10.1016/j.jff.2024.106436
|
| 103 |
Thomas Jensen, Amanda Wieland, Melanie Cree-Green, Kristen Nadeau, Shelby Sullivan. Clinical workup of fatty liver for the primary care provider. Postgraduate Medicine 2019; 131(1) doi: 10.1080/00325481.2019.1546532
|
| 104 |
Chanbin Lee, Jieun Kim, Youngmi Jung. Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Cells 2019; 8(10) doi: 10.3390/cells8101259
|
| 105 |
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International 2020; 14(6) doi: 10.1007/s12072-020-10094-2
|
| 106 |
Yayun Lu, Qing Xia, Liangyu Wu, Zhiping Xie. Gender difference in association between low muscle mass and risk of non-alcoholic fatty liver disease among Chinese adults with visceral obesity. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1026054
|
| 107 |
Amin Nakhostin-Ansari, Iman Menbari Oskouie, Reyhaneh Aghajani, Mohammad Mehdi Khadembashiri, Mohammad Ahmadi, Abdollah Gandomkar, Fatemeh Malekzadeh, Hossein Poustchi, Mohammad Reza Fattahi, Amir Anushiravani, Reza Malekzadeh. Prevalence and Correlates of Probable Nonalcoholic Steatohepatitis (NASH) in Pars Cohort Study. Archives of Iranian Medicine 2024; 27(11) doi: 10.34172/aim.30020
|
| 108 |
Katherine M. Cooper, Molly Delk, Deepika Devuni, Monika Sarkar. Sex differences in chronic liver disease and benign liver lesions. JHEP Reports 2023; 5(11) doi: 10.1016/j.jhepr.2023.100870
|
| 109 |
Amedeo Lonardo, Fabio Nascimbeni, Stefano Ballestri, DeLisa Fairweather, Sanda Win, Tin A. Than, Manal F. Abdelmalek, Ayako Suzuki. Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology 2019; 70(4) doi: 10.1002/hep.30626
|
| 110 |
Yao Yu, Jingjing Cai, Zhigang She, Hongliang Li. Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases. Advanced Science 2019; 6(4) doi: 10.1002/advs.201801585
|
| 111 |
Azam Doustmohammadian, Bahareh Amirkalali, Barbora de Courten, Saeed Esfandyari, Nima Motamed, Mansooreh Maadi, Hossein Ajdarkosh, Esmaeel Gholizadeh, Samira Chaibakhsh, Farhad Zamani. Path analysis model to identify the effect of poor diet quality on NAFLD among Iranian adults from Amol Cohort Study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-70181-4
|
| 112 |
Nora Anderson, Jürgen Borlak. Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis. Pharmacological Reviews 2008; 60(3) doi: 10.1124/pr.108.00001
|
| 113 |
Yong Jian Zhou, Zong Sheng Zhang, Yu Qiang Nie, Jie Cao, Chuang Yu Cao, Yu Yuan Li. Retracted: Association of adiponectin gene variation with progression of nonalcoholic fatty liver disease: A 4‐year follow‐up survey. Journal of Digestive Diseases 2015; 16(10) doi: 10.1111/1751-2980.12288
|
| 114 |
Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang. Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts. Endocrinology and Metabolism 2021; 36(4) doi: 10.3803/EnM.2021.1074
|
| 115 |
Erica Jennison, Christopher D. Byrne. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clinical and Molecular Hepatology 2021; 27(1) doi: 10.3350/cmh.2020.0129
|
| 116 |
Chuang-Yu Cao, Yu-Yuan Li, Yong-Jian Zhou, Yu-Qiang Nie, Yu-Jui Yvonne Wan. The C-681G Polymorphism of the PPAR-γ Gene Is Associated with Susceptibility to Non-Alcoholic Fatty Liver Disease. The Tohoku Journal of Experimental Medicine 2012; 227(4) doi: 10.1620/tjem.227.253
|
| 117 |
Wen Ji Chen, Bing Cai, Hui Ting Chen, Chuang Yu Cao, Yan Lei Du, Yu Yuan Li, Yu Qiang Nie, Yong Jian Zhou. Retracted: The role of ADIPOQ methylation in curcumin‐administrated experimental nonalcoholic fatty liver disease. Journal of Digestive Diseases 2016; 17(12) doi: 10.1111/1751-2980.12431
|
| 118 |
Ajay Duseja, Shivaram P. Singh, Vivek A. Saraswat, Subrat K. Acharya, Yogesh K. Chawla, Subhankar Chowdhury, Radha K. Dhiman, Rohinivilasam V. Jayakumar, Kaushal Madan, Sri P. Misra, Hrudananda Mishra, Sunil K. Modi, Arumugam Muruganathan, Banshi Saboo, Rakesh Sahay, Rajesh Upadhyay. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome—Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology. Journal of Clinical and Experimental Hepatology 2015; 5(1) doi: 10.1016/j.jceh.2015.02.006
|
| 119 |
Bi-xia Huang, Ming-fan Zhu, Ting Wu, Jing-ya Zhou, Yan Liu, Xiao-lin Chen, Rui-fen Zhou, Li-jun Wang, Yu-ming Chen, Hui-lian Zhu, Giovanni Targher. Neck Circumference, along with Other Anthropometric Indices, Has an Independent and Additional Contribution in Predicting Fatty Liver Disease. PLOS ONE 2015; 10(2) doi: 10.1371/journal.pone.0118071
|
| 120 |
Zhengli Tang, Minh Pham, Yiming Hao, Fang Wang, Devashru Patel, Lori Jean-Baptiste, Lin Fan, Weijian Wang, Yiqin Wang, Feng Cheng. Sex, Age, and BMI Modulate the Association of Physical Examinations and Blood Biochemistry Parameters and NAFLD: A Retrospective Study on 1994 Cases Observed at Shuguang Hospital, China. BioMed Research International 2019; 2019 doi: 10.1155/2019/1246518
|
| 121 |
Khadijah B. Alkinani, Ehab M. M. Ali, Turki M. Al-Shaikh, Jalaluddin A. Awlia Khan, Tahani M. Al-naomasi, Soad S. Ali, Asaad A. Abduljawad, Osama F. Mosa, Tariq A. Zafar, Ruchika Garg. Hepatoprotective Effects of (−) Epicatechin in CCl4-Induced Toxicity Model Are Mediated via Modulation of Oxidative Stress Markers in Rats. Evidence-Based Complementary and Alternative Medicine 2021; 2021 doi: 10.1155/2021/4655150
|
| 122 |
Manuel Jiménez‐García, Maria Magdalena Quetglas‐Llabrés, Maria del Mar Ribas‐Taberner, Antoni Sureda‐Gomila, David Moranta‐Mesquida, Silvia Tejada‐Gavela. Effects of Combining Exercise and Dietary Shifts on Motor Coordination and Oxidative Markers in a High‐Fat Diet Model in Rats. Comprehensive Physiology 2025; 15(6) doi: 10.1002/cph4.70074
|
| 123 |
Xinyu Han, Xin Zhang, Zhenqiu Liu, Hong Fan, Chengnan Guo, Haili Wang, Yu Gu, Tiejun Zhang. Prevalence of nonalcoholic fatty liver disease and liver cirrhosis in Chinese adults with type 2 diabetes mellitus. Journal of Diabetes 2024; 16(5) doi: 10.1111/1753-0407.13564
|
| 124 |
Nima Motamed, Mansooreh Maadi, Masoudreza Sohrabi, Hossein Keyvani, Hossein Poustchi, Farhad Zamani. Rural Residency has a Protective Effect and Marriage is a Risk Factor for NAFLD. Hepatitis Monthly 2016; 16(7) doi: 10.5812/hepatmon.38357
|
| 125 |
Ayako Suzuki, Manal F Abdelmalek. Nonalcoholic Fatty Liver Disease in Women. Women's Health 2009; 5(2) doi: 10.2217/17455057.5.2.191
|
| 126 |
Hong Deng, Chun-Ling Wang, Jing Lai, Su-Lin Yu, Dong-Ying Xie, Zhi-Liang Gao. Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients. Hepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.40263
|
| 127 |
Shiv K Sarin, Manoj Kumar, Mohammed Eslam, Jacob George, Mamun Al Mahtab, Sheikh M Fazle Akbar, Jidong Jia, Qiuju Tian, Rakesh Aggarwal, David H Muljono, Masao Omata, Yoshihiko Ooka, Kwang-Hyub Han, Hye Won Lee, Wasim Jafri, Amna S Butt, Chern H Chong, Seng G Lim, Raoh-Fang Pwu, Ding-Shinn Chen. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology 2020; 5(2) doi: 10.1016/S2468-1253(19)30342-5
|
| 128 |
Xin-Jie Dong, Jun-Yan Chen, Shu-Fen Chen, Yun Li, Xiu-Ju Zhao. The composition and anti-inflammatory properties of pumpkin seeds. Journal of Food Measurement and Characterization 2021; 15(2) doi: 10.1007/s11694-020-00783-9
|
| 129 |
Yang Xia, Zuolin Lu, Min Lu, Mingyue Liu, Li Liu, Ge Meng, Bin Yu, Hongmei Wu, Xue Bao, Yeqing Gu, Hongbin Shi, Honglei Wang, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Huiling Xiang, Zhong Sun, Kaijun Niu. Raw orange intake is associated with higher prevalence of non-alcoholic fatty liver disease in an adult population. Nutrition 2019; 60 doi: 10.1016/j.nut.2018.09.033
|
| 130 |
Julia A. Golubeva, Anna F. Sheptulina, Anastasia Yu. Elkina, Ekaterina O. Liusina, Anton R. Kiselev, Oxana M. Drapkina. Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?. Biomedicines 2023; 11(9) doi: 10.3390/biomedicines11092465
|
| 131 |
Jiawen Dong, Kaitlyn M J H Dennis, Radha Venkatakrishnan, Leanne Hodson, Jeremy W Tomlinson. The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy. Endocrine Reviews 2025; 46(6) doi: 10.1210/endrev/bnaf018
|
| 132 |
X. Wang, X. Chen, H. Zhang, J. Pang, J. Lin, X. Xu, L. Yang, J. Ma, W. Ling, Y. Chen. Circulating retinol-binding protein 4 is associated with the development and regression of non-alcoholic fatty liver disease. Diabetes & Metabolism 2020; 46(2) doi: 10.1016/j.diabet.2019.04.009
|
| 133 |
Gang Wu, Kai Wang, Yingming Xue, Guohe Song, Yupeng Wang, Xing Sun, Lin Zhong, Chongzhi Zhou, Bing Shen, Jian Chen, Yang Yu, Huamei Tang, Zhihai Peng, Peichun Sun, Xiaoliang Wang. Association of rs5764455 and rs6006473 polymorphisms in PARVB with liver damage of nonalcoholic fatty liver disease in Han Chinese population. Gene 2016; 575(2) doi: 10.1016/j.gene.2015.09.007
|
| 134 |
Winston Dunn, Zhen Zeng, Maura O'Neil, Jie Zhao, Melissa Whitener, Yu-Jui Y Wan, Erik K Mitchell, Michael Handler, Steven A Weinman. The Interaction of rs738409, Obesity, and Alcohol: A Population-Based Autopsy Study. American Journal of Gastroenterology 2012; 107(11) doi: 10.1038/ajg.2012.285
|
| 135 |
Sarah M. Lindbäck, Charles Gabbert, Benjamin L. Johnson, Emmanuil Smorodinsky, Claude B. Sirlin, Natalie Garcia, Perrie E. Pardee, Kristin D. Kistler, Jeffrey B. Schwimmer. Pediatric Nonalcoholic Fatty Liver Disease: A Comprehensive Review. Advances in Pediatrics 2010; 57(1) doi: 10.1016/j.yapd.2010.08.006
|
| 136 |
Shu-Fang Xia, Guo-Wei Le, Peng Wang, Yu-Yu Qiu, Yu-Yu Jiang, Xue Tang. Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet. Nutrients 2016; 8(12) doi: 10.3390/nu8120799
|
| 137 |
Joo Lee, Simonetta Friso, Sang-Woon Choi. Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition. Nutrients 2014; 6(8) doi: 10.3390/nu6083303
|
| 138 |
Marco Bertolotti, Amedeo Lonardo, Chiara Mussi, Enrica Baldelli, Elisa Pellegrini, Stefano Ballestri, Dante Romagnoli, Paola Loria. Nonalcoholic fatty liver disease and aging: Epidemiology to management. World Journal of Gastroenterology 2014; 20(39): 14185-14204 doi: 10.3748/wjg.v20.i39.14185
|
| 139 |
Chao Yang, Hui Xia, Min Wan, Yifei Lu, Dengfeng Xu, Xian Yang, Ligang Yang, Guiju Sun. Comparisons of the effects of different flaxseed products consumption on lipid profiles, inflammatory cytokines and anthropometric indices in patients with dyslipidemia related diseases: systematic review and a dose–response meta-analysis of randomized controlled trials. Nutrition & Metabolism 2021; 18(1) doi: 10.1186/s12986-021-00619-3
|
| 140 |
Elizabeth K. Speliotes, Joseph M. Massaro, Udo Hoffmann, Ramachandran S. Vasan, James B. Meigs, Dushyant V. Sahani, Joel N. Hirschhorn, Christopher J. O'Donnell, Caroline S. Fox. Fatty Liver Is Associated With Dyslipidemia and Dysglycemia Independent of Visceral Fat: the Framingham Heart Study. Hepatology 2010; 51(6) doi: 10.1002/hep.23593
|
| 141 |
Cui-Chun Zhao, Ai-Ping Wang, Lian-Xi Li, Ting-Ting Li, Ming-Yun Chen, Yue Zhu, Tian-Pei Yu, Yu-Qian Bao, Wei-Ping Jia. Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. Journal of Diabetes and its Complications 2016; 30(6) doi: 10.1016/j.jdiacomp.2016.04.017
|
| 142 |
Muhammad Adnan, Abdul Wajid, Wasif Noor, Andleeb Batool, Muhammad Aasim, Kamran Abbas, Quratul Ain. Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients. Journal of Genetic Engineering and Biotechnology 2022; 20(1) doi: 10.1186/s43141-022-00349-w
|
| 143 |
Yan Chen, Chuan Lu, Haonan Ju, Qingzhi Zhou, Xin Zhao. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017–2018. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1405828
|
| 144 |
Bipneet Singh, Sruthi Ramanan, Waryaam Singh, Gurleen Kaur, Palak Grover, Nidhishri Sridhar. NASH Cirrhosis: A Systematic Review of Phase 2B Trials. Open Journal of Gastroenterology 2025; 15(04) doi: 10.4236/ojgas.2025.154014
|
| 145 |
Yu-Yuan Li, Chuang-Yu Cao, You-lian Zhou, Yu-Qiang Nie, Jie Cao, Yong-Jian Zhou. The roles and interaction of FXR and PPARs in the pathogenesis of nonalcoholic fatty liver disease. Arab Journal of Gastroenterology 2020; 21(3) doi: 10.1016/j.ajg.2020.04.018
|
| 146 |
Karen L. Chen, Zeynep Madak-Erdogan. Estrogens and female liver health. Steroids 2018; 133 doi: 10.1016/j.steroids.2017.10.015
|
| 147 |
Gustavo Henrique Silva, Gabriel Hessel, Kunie Iabiku Rabello Coelho, Cecília Amélia Fazzio Escanhoela. Steatosis of indeterminate cause in a pediatric group: is it a primary mitochondrial hepatopathy?. Sao Paulo Medical Journal 2011; 129(4) doi: 10.1590/S1516-31802011000400004
|
| 148 |
Jie Yan, Wen Xie, Wei‐ni Ou, Hong Zhao, Su‐yun Wang, Jian‐hui Wang, Qi Wang, Yu‐ying Yang, Xin Feng, Jun Cheng. Epidemiological survey and risk factor analysis of fatty liver disease of adult residents, Beijing, China. Journal of Gastroenterology and Hepatology 2013; 28(10) doi: 10.1111/jgh.12290
|
| 149 |
Jian‐Gao Fan. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. Journal of Gastroenterology and Hepatology 2013; 28(S1) doi: 10.1111/jgh.12036
|
| 150 |
Guo-Zhong Ji, Xiao-Zhong Yang, Rui Xie, Fa-Ming Zhang, Xiao-Dan Huang, Peng Shen, Hang-Jiang Fu, Li-Zhen Wang, Hong-Gang Wang. Cholecystectomy does not significantly increase the risk of fatty liver disease. World Journal of Gastroenterology 2015; 21(12): 3614-3618 doi: 10.3748/wjg.v21.i12.3614
|
| 151 |
Xiaona Hu, Yiqin Huang, Zhijun Bao, Yiqian Wang, Dongmei Shi, Fang Liu, Zhanjuan Gao, Xiaofeng Yu. Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-123
|
| 152 |
Harmesh N. Chaudhari, Jong Won Yun. DJ-1 deficiency alleviates steatosis in cultured hepatocytes. Biotechnology and Bioprocess Engineering 2015; 20(6) doi: 10.1007/s12257-015-0689-5
|
| 153 |
Kirti Shetty, Jian Chen, Ji-hyun Shin, Wilma Jogunoori, Lopa Mishra. Pathogenesis of Hepatocellular Carcinoma Development in Non-alcoholic Fatty Liver Disease. Current Hepatology Reports 2015; 14(2) doi: 10.1007/s11901-015-0260-z
|
| 154 |
Shivakumar Chitturi, Vincent Wai‐Sun Wong, Geoff Farrell. Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground. Journal of Gastroenterology and Hepatology 2011; 26(s1) doi: 10.1111/j.1440-1746.2010.06548.x
|
| 155 |
Maki Tobari, Etsuko Hashimoto. Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index. Gut and Liver 2020; 14(5) doi: 10.5009/gnl19236
|
| 156 |
P. Briseño-Bass, R. Chávez-Pérez, M. López-Zendejas. Prevalence of hepatic steatosis and its relation to liver function tests and lipid profile in patients at medical check-up. Revista de Gastroenterología de México (English Edition) 2019; 84(3) doi: 10.1016/j.rgmxen.2018.05.024
|
| 157 |
Tokan Silas Baduku, Philip Oluleke Ibinaiye, Joseph Bako Igashi, Bello Omuya Usman, Muhammad Manko, Abdurrahman El-fulaty Ahmad, Abdulkadir Musa Tabari, Shettima Kagu Mustapha, Adebanke Sefiya Olarinoye-Akorede, Muhammad Shakir Balogun. B-Mode Ultrasound Grading of Nonalcoholic Fatty Liver Disease and Association with Intima-media Thickness: A Case–Control Study. Journal of the Nigerian Academy of Medicine 2024; 3(1) doi: 10.4103/jnam.jnam_4_23
|
| 158 |
Aalia Tahseen, Suchitra Kumari, Manaswini Mangaraj, Manas K Panigrahi. The Potential Role of Serum Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) as a Biomarker of Fibrosis in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) . Cureus 2025; doi: 10.7759/cureus.96047
|
| 159 |
Naim Alkhouri, Gareth Morris‐Stiff, Carla Campbell, Rocio Lopez, Tarek Abu‐Rajab Tamimi, Lisa Yerian, Nizar N. Zein, Ariel E. Feldstein. Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver International 2012; 32(2) doi: 10.1111/j.1478-3231.2011.02639.x
|
| 160 |
Seok-Chin Goh, Evelyn Lai-Ming Ho, Khean-Lee Goh. Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia. Hepatology International 2013; 7(2) doi: 10.1007/s12072-012-9359-2
|
| 161 |
Rosemay A. Remigio-Baker, Matthew A. Allison, Nketi I. Forbang, Rohit Loomba, Cheryl A.M. Anderson, Matthew Budoff, Jeffrey B. Schwimmer, Roger S. Blumenthal, Pamela Ouyang, Michael H. Criqui. Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2017; 258 doi: 10.1016/j.atherosclerosis.2016.11.021
|